Back to Markets
BCBioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc

BCRXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$8.91

-0.190000 (-2.09%)

As of 05/29/26 EDT · USD

Compare
Low: $6.00Current: $8.91High: $11.31

Key Statistics

Open

$9.05

Day High

$9.10

Day Low

$8.82

Prev. Close

$9.10

VolumeShares traded today.

3.07M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$2.27B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-5.02

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$11.31

52W LowLowest price over the past 52 weeks.

$6.00

50D MAAverage closing price over the last 50 trading days.

$9.18

200D MAAverage closing price over the last 200 trading days.

$7.92

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.5%

1M

-0.9%

6M

+30.1%

YTD

+18.8%

1Y

-17.0%

About

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

www.biocryst.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade BCRX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.